FDA Decisions to Look For in 1H 2026 CGTlive A new FDA advisory panel meeting, influenced by RFK Jr.'s push for broader access, will weigh the potential benefits and risks of widely promoted peptides. Click the link in bio to read CDER Brings Many Safe and Effective Therapies to Patients and Consumers in 2024 FDA Dihexa Capsules 30 x 10mg Bioniq Lab Peptides Made Personal BPC 157 FDA Approval Status 2026: RFK Jr, Advisory Committee & Reclassification